Power of AI & Big Data in Disrupting Medicine and Healthcare Delivery
Join us for a panel discussion on how artificial intelligence (AI) & Big Data are and will be disrupting medicine and healthcare delivery due to recent advancements in AI, rapid development in Big Data analytics, and their great potential in revolutionizing healthcare operations, drug discovery, biomedical research, and patient-centered care delivery. The moderator and speakers, including leaders in technology, industry, strategy, investment, and regulatory affairs, will address the following:
• Current and future most promising applications of AI & Big Data in transforming healthcare operations,
drug discovery, biomedical research, and medical care delivery
• Opportunities and challenges for investors and entrepreneurs in healthcare AI & Big Data analytics sector
• Partnerships among different stakeholders (e.g., technology companies, pharmaceutical companies)
to unleash value of AI & Big Data in disrupting research and development
• New regulations and reimbursement models in innovative medical care delivery using AI & Big Data
• Evolving regulatory landscape and future opportunities & challenges in the use of real-world data (RWD)
and real-world evidence (RWE)
• Privacy issues, ethics concerns, and medical errors related to AI & Big Data use in medicine and healthcare delivery
Roger Cohen, Partner, Goodwin Procter
Harold Mondschein, CEO & Co-founder, Medtel
Wendy Perchick, SVP of Strategy and Innovation, Memorial Sloan Kettering Cancer Center
Dr. Rafael Torgovicky, General Partner, Accelmed Partners II
(Moderator) Raymond Falci, Adjunct Professor, Columbia Business School
Date: Tuesday, February 11, 2020
Time: 6:00 pm - 8:30 pm (the discussion will take place approximately 6:30 - 8:00 pm with time for networking before and after.)
Location: Goodwin Procter, 620 Eighth Ave. (best entrance on W. 41st St.), NYC
Tickets: $35 for CBSACNY members; $60 for CBSACNY non-members
SPECIAL OFFER: Columbia Business School Alumni Club of New York offers ONE FREE EVENT (including this one) for new members who sign up for the first time ($85 or more). Click here to join now and then contact us to receive your promotional code before you register for the event of your choice (sports events, holiday parties and mixers are excluded.)
Roger A. Cohen is a partner in Goodwin’s nationally recognized Life Sciences practice. He counsels healthcare services, life sciences, and healthcare IT clients concerning compliance with the myriad laws and regulations governing the delivery of healthcare services such as the Anti-Kickback Statute, the Physician Self-Referral Law (the Stark Law), the False Claims Act, the Health Insurance Portability and Accountability Act of 1996 (HIPAA), Medicare and Medicaid rules and regulations, and laws governing reimbursement, licensure and certification. Mr. Cohen’s experience also includes extensive work on healthcare transactions. He has represented clients in acquisitions and financings involving a wide variety of healthcare providers including hospitals, ambulatory surgery centers, physician groups, skilled nursing facilities, rehabilitation and physical therapy facilities, behavioral health and substance abuse treatment providers, dental clinics, home healthcare providers, clinical laboratories, pharmacies, and care management companies, among others. Mr. Cohen also has deep experience assisting clients in transactions involving and providing counsel to health IT -- companies such as telemedicine providers and electronic health record, mobile health (mHealth), and digital health companies.
Harold Mondschein has more than 20 years of leadership experience in the healthcare sector, including direct patient care, sales, and consulting for health systems and manufacturers. This blend of experiences and his deep understanding of the surgical care process uncovered a need for innovation that is plagued by manual-based processes and a lack of proactivity. Incorporating patient outcomes and experiences as Medtel’s guiding principle, Harold applied the knowledge and expertise that he acquired as a neurological specialist in physical therapy, and the advantages of an interdisciplinary approach to patient care. It was at NYU Medical Center, and then later successfully launching a state-of-the-art neurosurgery rehabilitation program at Beth Israel Medical Center’s Institute for Neurology and Neurosurgery that care coordination and a systematic approach to surgical care was engrained. Prior to Medtel, Mr. Mondschein was a Managing Partner at Proficient Surgical Equipment, a leading medical device distribution company specializing in innovative technologies in surgical care.
As a result of Mr. Mondschein’s blend of medical technology understanding, along with his experiences and knowledge of the healthcare industry, he has become a valued speaker at symposiums, conferences, and universities on the topics of healthcare technologies, value-based care, same day surgery, and entrepreneurship.
Senior Vice President of Strategy and Innovation Wendy Perchick plays a pivotal role in charting the organization’s strategic direction – combining a unique focus in cancer research and care delivery with the power of data and analytics. As the executive in charge of initiatives aimed at expanding access to leading cancer care, she helped plan the overall expansion of the MSK clinical enterprise and the initiation of the MSK Cancer Alliance. Ms. Perchick explored the use of decision support from her team’s work on IBM Watson cancer training, the use of digital outreach, and platform technology to support early interception of high-risk individuals for cancer through the Precision Intervention Program. Ms. Perchick, a New York native, first came to MSK in 1976 and is committed to the mission and vision of this world class organization. During her time at the institution, she held many roles in the administrative leadership of research initiatives and academic departments. She also led the design of the transformation for the outpatient delivery model. Ms. Perchick combines a deep knowledge of hospital operations and a track record for developing innovative models for improving the delivery models of cancer care. In 2006, Ms. Perchick initiated the Division of Strategy and Innovation at MSK — combining strategy, business development, analytics and design innovation into a new and dynamic expertise within the organization. In 2012, her team’s work in quantitative analytics was recognized by the Society of Operations Research INFORMS prize. Ms. Perchick and her team are currently engaged in tackling the issues of access to high quality care and affordability for people with cancer.
Dr. Rafael Torgovicky
Dr. Rafael Torgovicky is an internationally recognized physician-entrepreneur, executive and investor, with over 15 years of clinical and industry healthcare experience. He is currently a General Partner at Accelmed Partners II leading the Digital Health investments for the fund. Dr. Torgovicky also serves as an advisor to the i3 Asset Accelerator at Mount Sinai. He was instrumental in the founding of number of life sciences companies; business and educational initiatives in this field. Dr. Torgovicky previously held leadership positions of increasing responsibility in the pharmaceutical industry, with Novartis, Merck & Co, and most recently Eli Lilly & Co where he served as Vice President, External Innovation – Oncology. Over the years, he has lectured in multiple conferences and academic classes and has authored several peer-reviewed manuscripts and book chapters. Dr. Torgovicky received his MD and MBA degrees from Tel-Aviv University, Israel and obtained postgraduate training in Pharmaceutical medicine at Basel University, Switzerland.
Raymond G. Falci (Moderator)
Raymond G. Falci currently serves on several healthcare boards and is an adjunct professor at Columbia Business School, having previously worked on Wall Street for 20+ years. Mr. Falci was a Managing Director at Cain Brothers from 2006 to 2016, serving on the Executive Committee and co-heading the firm’s Services & Technology practice. Ray’s banking focus included Healthcare IT and Revenue Cycle Management as well as healthcare distribution, specialty pharmacy and PBMs. Prior to joining Cain Brothers, Mr. Falci was an equity research analyst for 9 years, primarily at Bear Stearns where he was named to Institutional Investor’s All-Star Team for five consecutive years, including two number 1 rankings. Ray’s research universe included Health Care IT, Distribution, CROs, and Hospitals. Ray worked in sales and engineering in the energy efficiency industry for 7 years prior to commencing his Wall Street career. Mr. Falci graduated from The Cooper Union with a Bachelor’s of Engineering in Mechanical Engineering, earned a Master’s Degree from Columbia University in Mechanical Engineering and an MBA from the Wharton School of the University of Pennsylvania.
Thanks to the Healthcare Committee of the CBS Alumni Club of NY - Deepak Mittal '10, Chairman, Feng (Johnson) Qian '18, Vice Chairman, and Wendy Diller, for coordinating the program. And special thanks to our host, Goodwin Proctor.